vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and STEPAN CO (SCL). Click either name above to swap in a different company.

Everus Construction Group, Inc. is the larger business by last-quarter revenue ($1.0B vs $604.5M, roughly 1.7× STEPAN CO). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs 3.3%, a 2.2% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 1.9%). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 4.2%).

Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.

ECG vs SCL — Head-to-Head

Bigger by revenue
ECG
ECG
1.7× larger
ECG
$1.0B
$604.5M
SCL
Growing faster (revenue YoY)
ECG
ECG
+31.3% gap
ECG
33.2%
1.9%
SCL
Higher net margin
ECG
ECG
2.2% more per $
ECG
5.5%
3.3%
SCL
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
4.2%
SCL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ECG
ECG
SCL
SCL
Revenue
$1.0B
$604.5M
Net Profit
$55.3M
$19.7M
Gross Margin
11.6%
10.7%
Operating Margin
6.8%
4.7%
Net Margin
5.5%
3.3%
Revenue YoY
33.2%
1.9%
Net Profit YoY
60.4%
EPS (diluted)
$1.09
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
SCL
SCL
Q1 26
$604.5M
Q4 25
$1.0B
$553.9M
Q3 25
$986.8M
$590.3M
Q2 25
$921.5M
$594.7M
Q1 25
$826.6M
$593.3M
Q4 24
$759.6M
$525.6M
Q3 24
$761.0M
$546.8M
Q2 24
$703.4M
$556.4M
Net Profit
ECG
ECG
SCL
SCL
Q1 26
$19.7M
Q4 25
$55.3M
$5.0M
Q3 25
$57.0M
$10.8M
Q2 25
$52.8M
$11.3M
Q1 25
$36.7M
$19.7M
Q4 24
$34.5M
$3.4M
Q3 24
$41.8M
$23.6M
Q2 24
$39.0M
$9.5M
Gross Margin
ECG
ECG
SCL
SCL
Q1 26
10.7%
Q4 25
11.6%
9.3%
Q3 25
12.6%
12.0%
Q2 25
13.0%
12.1%
Q1 25
11.2%
12.7%
Q4 24
11.4%
10.8%
Q3 24
11.8%
13.8%
Q2 24
12.6%
12.5%
Operating Margin
ECG
ECG
SCL
SCL
Q1 26
4.7%
Q4 25
6.8%
1.9%
Q3 25
7.3%
3.7%
Q2 25
7.9%
3.0%
Q1 25
6.2%
4.8%
Q4 24
6.1%
1.5%
Q3 24
7.1%
4.4%
Q2 24
7.3%
3.4%
Net Margin
ECG
ECG
SCL
SCL
Q1 26
3.3%
Q4 25
5.5%
0.9%
Q3 25
5.8%
1.8%
Q2 25
5.7%
1.9%
Q1 25
4.4%
3.3%
Q4 24
4.5%
0.6%
Q3 24
5.5%
4.3%
Q2 24
5.5%
1.7%
EPS (diluted)
ECG
ECG
SCL
SCL
Q1 26
$0.86
Q4 25
$1.09
$0.22
Q3 25
$1.11
$0.47
Q2 25
$1.03
$0.50
Q1 25
$0.72
$0.86
Q4 24
$0.68
$0.14
Q3 24
$0.82
$1.03
Q2 24
$0.76
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
SCL
SCL
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$281.5M
$328.4M
Stockholders' EquityBook value
$629.8M
$1.2B
Total Assets
$1.7B
$2.3B
Debt / EquityLower = less leverage
0.45×
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
SCL
SCL
Q1 26
Q4 25
$132.7M
Q3 25
$118.5M
Q2 25
$88.9M
Q1 25
$107.5M
Q4 24
$99.7M
Q3 24
$553.0K
$147.3M
Q2 24
$124.7M
Total Debt
ECG
ECG
SCL
SCL
Q1 26
$328.4M
Q4 25
$281.5M
$626.7M
Q3 25
$285.1M
$655.5M
Q2 25
$288.6M
$658.0M
Q1 25
$292.1M
$659.3M
Q4 24
$295.6M
$625.4M
Q3 24
$688.5M
Q2 24
$657.1M
Stockholders' Equity
ECG
ECG
SCL
SCL
Q1 26
$1.2B
Q4 25
$629.8M
$1.2B
Q3 25
$573.0M
$1.2B
Q2 25
$514.4M
$1.2B
Q1 25
$460.2M
$1.2B
Q4 24
$422.6M
$1.2B
Q3 24
$453.3M
$1.2B
Q2 24
$490.0M
$1.2B
Total Assets
ECG
ECG
SCL
SCL
Q1 26
$2.3B
Q4 25
$1.7B
$2.4B
Q3 25
$1.6B
$2.4B
Q2 25
$1.5B
$2.4B
Q1 25
$1.4B
$2.4B
Q4 24
$1.3B
$2.3B
Q3 24
$1.3B
$2.4B
Q2 24
$2.3B
Debt / Equity
ECG
ECG
SCL
SCL
Q1 26
0.28×
Q4 25
0.45×
0.50×
Q3 25
0.50×
0.53×
Q2 25
0.56×
0.53×
Q1 25
0.63×
0.55×
Q4 24
0.70×
0.53×
Q3 24
0.56×
Q2 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
SCL
SCL
Operating Cash FlowLast quarter
$48.2M
Free Cash FlowOCF − Capex
$23.5M
FCF MarginFCF / Revenue
2.3%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
0.87×
TTM Free Cash FlowTrailing 4 quarters
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
SCL
SCL
Q1 26
Q4 25
$48.2M
$60.0M
Q3 25
$76.2M
$69.8M
Q2 25
$25.3M
$11.2M
Q1 25
$7.1M
$6.9M
Q4 24
$68.3M
Q3 24
$78.9M
$22.7M
Q2 24
$29.5M
Free Cash Flow
ECG
ECG
SCL
SCL
Q1 26
Q4 25
$23.5M
$25.4M
Q3 25
$65.7M
$40.2M
Q2 25
$12.3M
$-14.4M
Q1 25
$-11.4M
$-25.8M
Q4 24
$32.1M
Q3 24
$60.9M
$-4.0M
Q2 24
$-208.0K
FCF Margin
ECG
ECG
SCL
SCL
Q1 26
Q4 25
2.3%
4.6%
Q3 25
6.7%
6.8%
Q2 25
1.3%
-2.4%
Q1 25
-1.4%
-4.3%
Q4 24
6.1%
Q3 24
8.0%
-0.7%
Q2 24
-0.0%
Capex Intensity
ECG
ECG
SCL
SCL
Q1 26
Q4 25
2.4%
6.3%
Q3 25
1.1%
5.0%
Q2 25
1.4%
4.3%
Q1 25
2.2%
5.5%
Q4 24
6.9%
Q3 24
2.4%
4.9%
Q2 24
5.3%
Cash Conversion
ECG
ECG
SCL
SCL
Q1 26
Q4 25
0.87×
11.99×
Q3 25
1.34×
6.44×
Q2 25
0.48×
0.99×
Q1 25
0.19×
0.35×
Q4 24
20.38×
Q3 24
1.89×
0.96×
Q2 24
3.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

SCL
SCL

Surfactants$453.7M75%
Polymers$130.0M22%
Specialty Products$20.8M3%

Related Comparisons